Indirizzo: Via Portuense, 292     Telefono: +39 06.55170.1    

Menu

INMI Lazzaro Spallanzani
Istituto Nazionale Malattie Infettive

Menu principale

Pubblicazioni 2020

  1. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study COVID-19 RISK and Treatments (CORIST). Eur J Intern Med 2020 Aug 25; S0953
  2. Giammauro Berardi, Marco Colasanti, Giovanni Battista Levi Sandri, Celeste Del Basso, Stefano Ferretti, Andrea Laurenzi, Nicola Guglielmo, Roberto Luca Meniconi, Mario Antonini, Gianpiero D’Offizi, Giuseppe Maria Ettorre. Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center Updates Surg 2020 Jun;72(2):281-289
  3. Bordoni V, Sacchi A, Cimini E, Notari S, Grassi G, Tartaglia E, Casetti R, Giancola L, Bevilacqua N, Maeurer M, Zumla A, Locatelli F, De Benedetti F, Palmieri F, Marchioni L, Capobianchi MR, D’Offizi G, Petrosillo N, Antinori A, Nicastri E, Ippolito G, Agrati C. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19. Clin Infect Dis. 2020 May 15
  4. Nicastri E, Petrosillo N, Ascoli Bartoli T, Lepore L, Mondi A, Palmieri F, D’Offizi G, Marchioni L, Murachelli S, Ippolito G, Antinori A National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep. 2020 Mar
  5. Tempestilli M, Caputi P, Avataneo V, Notari S, Forini O, Scorzolini L, Marchioni L, Ascoli Bartoli T, Castilletti C, Lalle E, Capobianchi MR, Nicastri E, D’Avolio A, Ippolito G, Agrati C; COVID 19 INMI Study Group. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. J Antimicrob Chemother. 2020 Oct 1;75(10):2977-2980.
  6. Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D’Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 Nov 9;222(11):1807-1815.
  7. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. COVID-19 RISk and Treatments (CORIST) Collaboration. Vascul Pharmacol. 2020 Dec;135:106805.
  8. Sacchi A, Grassi G, Bordoni V, Lorenzini P, Cimini E, Casetti R, Tartaglia E, Marchioni L, Petrosillo N, Palmieri F, D’Offizi G, Notari S, Tempestilli M, Capobianchi MR, Nicastri E, Maeurer M, Zumla A, Locatelli F, Antinori A, Ippolito G, Agrati C. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 Oct 27;11(10):921
  9. Montalbano M, Levi Sandri GB, Visco Comandini U, Lionetti R, Vincenzi L, Berardi G, Guglielmo N, Pellicelli A, Ettorre GM, D’Offizi G. The impact of the coronavirus disease 2019 pandemic on a central Italy transplant center. Medicine (Baltimore). 2020 Oct 9;99(41):e22174.
  10. Minosse C, Biliotti E, Lapa D, Rianda A, Marchili M, Luzzitelli I, Capobianchi MR, McPhee F, Garbuglia AR, D’Offizi G. Clinical Characteristics of Acute Hepatitis E and Their Correlation with HEV Genotype 3 Subtypes in Italy. Pathogens. 2020 Oct 11;9(10):832.
  11. Lampertico P, Berg T, Buti M, Pathil A, Petersen J, Ryder SD, Zoulim F, Botros I, Flaherty JF, Jump B, Op den Brouw ML, van Troostenburg A, Ramroth H; ReCoRd (Retrospective, Cohort, Renal, Viread) Investigators’ GroupTreatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study. Aliment Pharmacol Ther. 2020 Aug;52(3):500-512.
  12. Baiocchini A, Del Nonno F, Taibi C, Visco-Comandini U, D’Offizi G, Piacentini M, Falasca L. Publisher Correction: Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C. Sci Rep. 2020 Jan 24;10(1):1420.
  13. Lanini S, Montaldo C, Nicastri E, Vairo F, Agrati C, Petrosillo N, Scognamiglio P, Antinori A, Puro V, Di Caro A, De Carli G, Navarra A, Agresta A, Cimaglia C, Palmieri F, D’Offizi G, Marchioni L, Kobinger GP, Maeurer M, Girardi E, Capobianchi MR, Zumla A, Locatelli F, Ippolito G. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020 Dec 28;15(12)
  14. Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N, Blandi L, Bruno R, Cauda R, Guaraldi G, My I, Menicanti L, Parruti G, Patti G, Perlini S, Santilli F, Signorelli C, Stefanini GG, Vergori A, Abdeddaim A, Ageno W, Agodi A, Agostoni P, Aiello L, Al Moghazi S, Aucella F, Barbieri G, Bartoloni A, Bologna C, Bonfanti P, Brancati S, Cacciatore F, Caiano L, Cannata F, Carrozzi L, Cascio A, Cingolani A, Cipollone F, Colomba C, Crisetti A, Crosta F, Danzi GB, D’Ardes D, de Gaetano Donati K, Di Gennaro F, Di Palma G, Di Tano G, Fantoni M, Filippini T, Fioretto P, Fusco FM, Gentile I, Grisafi L, Guarnieri G, Landi F, Larizza G, Leone A, Maccagni G, Maccarella S, Mapelli M, Maragna R, Marcucci R, Maresca G, Marotta C, Marra L, Mastroianni F, Mengozzi A, Menichetti F, Milic J, Murri R, Montineri A, Mussinelli R, Mussini C, Musso M, Odone A, Olivieri M, Pasi E, Petri F, Pinchera B, Pivato CA, Pizzi R, Poletti V, Raffaelli F, Ravaglia C, Righetti G, Rognoni A, Rossato M, Rossi M, Sabena A, Salinaro F, Sangiovanni V, Sanrocco C, Scarafino A, Scorzolini L, Sgariglia R, Simeone PG, Spinoni E, Torti C, Trecarichi EM, Vezzani F, Veronesi G, Vettor R, Vianello A, Vinceti M, De Caterina R, Iacoviello L; COvid-19 RISk and Treatments (CORIST) collaboration. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913
  15. Calogero A, Gallo M, Sica A, Peluso G, Scotti A, Tammaro V, Carrano R, Federico S, Lionetti R, Amato M, Carlomagno N, Dodaro CA, Sagnelli C, Santangelo M. Gastroenterological complications in kidney transplant patients. Open Med (Wars). 2020 Jul 11;15(1):623-634
  16. Bentzon AK, Panteleev A, Mitsura V, Borodulina E, Skrahina A, Denisova E, Tetradov S, Podlasin R, Riekstina V, Kancauskiene Z, Paduto D, Mocroft A, Trofimova T, Miller R, Post F, Grezesczuk A, Lundgren JD, Inglot M, Podlekareva D, Bolokadze N, Kirk O; TB:HIV Study Group. Healthcare delivery for HIV-positive people with tuberculosis in Europe. HIV Med. 2020 Nov 20
  17. Petrosillo N, Cataldo MA. Clostridioides difficile Infection: A Room for Multifaceted Interventions. J Clin Med. 2020 Dec 20;9(12):4114.
  18. Lanini S, Montaldo C, Nicastri E, Vairo F, Agrati C, Petrosillo N, Scognamiglio P, Antinori A, Puro V, Di Caro A, De Carli G, Navarra A, Agresta A, Cimaglia C, Palmieri F, D’Offizi G, Marchioni L, Kobinger GP, Maeurer M, Girardi E, Capobianchi MR, Zumla A, Locatelli F, Ippolito G. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020 Dec 28;15(12):e0244129.
  19. Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, Petrosillo N, Mastroianni C, Cascio A, Iaria C, Galli M, Chirianni A, Sagnelli E, Iacobello C, Di Perri G, Mazzotta F, Carosi G, Tinelli M, Grossi P, Armignacco O, Portelli V, Andreoni M, Tavio M; Italian Society of Infectious and Tropical Diseases. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT). Clin Microbiol Infect. 2020 Dec 22:S1198-743X(20)30770-9. doi: 10.1016/j.cmi.2020.12.011
  20. Palmieri L, Palmer K, Lo Noce C, Meli P, Giuliano M, Floridia M, Tamburo de Bella M, Piccioli A, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group (*). Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy. Aging Clin Exp Res. 2020 Dec 21:1–7.
  21. Petrosillo N. Introducing Infectious Disease Reports: Past, Present and Future. Infect Dis Rep. 2020 Dec 11;12(3):132-133.
  22. Bedos JP, Daikos G, Dodgson AR, Pan A, Petrosillo N, Seifert H, Vila J, Ferrer R, Wilson P. Early identification and optimal management of carbapenem-resistant Gram-negative infection. J Hosp Infect. 2020 Dec 5:S0195-6701(20)30553-3.
  23. Vita S, Di Bari V, Corpolongo A, Goletti D, Espinosa J, Petracca S, Palmieri F, Nicastri E; INMI COVID-19 study groups. Down Syndrome patients with COVID-19 pneumonia: a high-risk category for unfavourable outcome. Int J Infect Dis. 2020 Nov 30:S1201-9712(20)32503-0.
  24. Granata G, Bartoloni A, Codeluppi M, Contadini I, Cristini F, Fantoni M, Ferraresi A, Fornabaio C, Grasselli S, Lagi F, Masucci L, Puoti M, Raimondi A, Taddei E, Trapani FF, Viale P, Johnson S, Petrosillo N, On Behalf Of The CloVid Study Group. The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid). J Clin Med. 2020 Nov 27;9(12):3855.
  25. Del Nonno F, Frustaci A, Verardo R, Chimenti C, Nicastri E, Antinori A, Petrosillo N, Lalle E, Agrati C, Ippolito G; INMI COVID study group. Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series. Circ Heart Fail. 2020 Nov 12;13(11):CIRCHEARTFAILURE120007636
  26. Cataldo MA, Tetaj N, Selleri M, Marchioni L, Capone A, Caraffa E, Caro AD, Petrosillo N; INMICOVID-19 Co-infection Group. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”. J Glob Antimicrob Resist. 2020 Dec;23:290-291.
  27. Grippo F, Navarra S, Orsi C, Manno V, Grande E, Crialesi R, Frova L, Marchetti S, Pappagallo M, Simeoni S, Di Pasquale L, Carinci A, Donfrancesco C, Lo Noce C, Palmieri L, Onder G, Minelli G; Italian National Institute of Health Covid-Mortality Group. The Role of COVID-19 in the Death of SARS-CoV-2-Positive Patients: A Study Based on Death Certificates. J Clin Med. 2020 Oct 27;9(11):3459.
  28. Sacchi A, Grassi G, Bordoni V, Lorenzini P, Cimini E, Casetti R, Tartaglia E, Marchioni L, Petrosillo N, Palmieri F, D’Offizi G, Notari S, Tempestilli M, Capobianchi MR, Nicastri E, Maeurer M, Zumla A, Locatelli F, Antinori A, Ippolito G, Agrati C. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 Oct 27;11(10):921
  29. Bordi L, Sberna G, Lalle E, Piselli P, Colavita F, Nicastri E, Antinori A, Boumis E, Petrosillo N, Marchioni L, Minnucci G, D’Agostini E, Castilletti C, Locatelli F, Zumla A, Ippolito G, Capobianchi MR, On Behalf Of Inmi ReCOVeRI Study Group. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 Oct 20;12(10):1184
  30. Raparelli V, Palmieri L, Canevelli M, Pricci F, Unim B, Lo Noce C, Villani ER, Rochon PA, Pilote L, Vanacore N, Onder G; Italian National Institute of Health COVID-19 Mortality Group. Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy. Biol Sex Differ. 2020 Oct 16;11(1):57.
  31. Canevelli M, Palmieri L, Raparelli V, Punzo O, Donfrancesco C, Lo Noce C, Vanacore N, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group. COVID-19 mortality among migrants living in Italy. Ann Ist Super Sanita. 2020 Jul-Sep;56(3):373-377.
  32. Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D’Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 Nov 9;222(11):1807-1815
  33. Granata G, Manissero D, Oppia MV, Tone K, Cai B, Longshaw C, Venditti C, Petrosillo N. Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review. Infect Dis Rep. 2020 Aug 5;12(2):8510.
  34. Abadi ATB, Petrosillo N, Kavoor AR. Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains. Vacunas. 2020 Aug 28.
  35. Chinello P, Granata G, Galati V, et al. Salmonella Hessarek Gastroenteritis with Bacteremia: A Case Report and Literature Review. Pathogens. 2020;9(8):E656. Published 2020 Aug 15. doi:10.3390/pathogens9080656
  36. Onder G, Palmieri L, Vanacore N, Giuliano M, Brusaferro S; Italian National Institute of Health COVID-19 mortality group. Non-respiratory Complications and Obesity in Patients Dying with COVID-19 in Italy [published online ahead of print, 2020 Aug 18]. Obesity (Silver Spring). 2020;10.1002/oby.23007. doi:10.1002/oby.23007
  37. Romanò CL, Petrosillo N, Argento G, et al. The Role of Imaging Techniques to Define a Peri-Prosthetic Hip and Knee Joint Infection: Multidisciplinary Consensus Statements. J Clin Med. 2020;9(8):E2548. Published 2020 Aug 6. doi:10.3390/jcm9082548
  38. Giacobbe DR, Dettori S, Di Bella S, et al. Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies. Infect Dis Ther. 2020;9(3):481-494. doi:10.1007/s40121-020-00314-5
  39. Petersen E, Koopmans M, Go U, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20(9):e238-e244. doi:10.1016/S1473-3099(20)30484-9
  40. De Nardo P, Gentilotti E, Mazzaferri F, et al. Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage [published online ahead of print, 2020 Jun 30]. Int J Infect Dis. 2020;98:494-500. doi:10.1016/j.ijid.2020.06.082
  41. Solinas C, Perra L, Aiello M, Migliori E, Petrosillo N. A critical evaluation of glucocorticoids in the management of severe COVID-19 [published online ahead of print, 2020 Jun 24]. Cytokine Growth Factor Rev. 2020;S1359-6101(20)30161-1.
  42. Tempestilli M, Caputi P, Avataneo V, Notari S, Forini O, Scorzolini L, Marchioni L, Ascoli Bartoli T, Castilletti C, Lalle E, Capobianchi MR, Nicastri E, D’Avolio A, Ippolito G, Agrati C; COVID 19 INMI Study Group. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. J Antimicrob Chemother. 2020 Oct 1;75(10):2977-2980.
  43. Petrosillo N. SARS-CoV-2, “Common Cold” Coronaviruses’ Cross-Reactivity and “Herd Immunity”: The Razor of Ockham (1285-1347)? Infect Dis Rep 2020;12(2):8647.
  44. Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, Raparelli V, Pezzotti P, Riccardo F, Bella A, Fabiani M, D’Ancona FP, Vaianella L, Tiple D, Colaizzo E, Palmer K, Rezza G, Piccioli A, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1796-1800
  45. Bassetti M, Vena A, Giacobbe DR et al. Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study). Open Forum Infect Dis 2020; 7(5):ofaa139.
  46. Zumla A, Wang F-S, Chang C, et al. Reducing Mortality and Morbidity in Patients With Severe COVID-19 Disease by Advancing Ongoing Trials of Mesenchymal Stromal (Stem) Cell (MSC) Therapy – Achieving Global Consensus and Visibility for Cellular Host-Directed Therapies. Int J Infect Dis 2020;96:431-439.
  47. Bordoni V, Sacchi A, Cimini E et al. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in COVID-19. Clin Infect Dis 2020 May 15;ciaa577.
  48. Bassetti M, Giacobbe DR, Aliberti S et al. Balancing Evidence and Frontline Experience in the Early Phases of the COVID-19 Pandemic: Current Position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect 2020 Apr 29;S1198-743X(20)30257-3.
  49. Badagliacca R, Sciomer S, Petrosillo N. Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension and COVID-19: Friend or Foe? J Heart Lung Transplant 2020 Apr 17;S1053-2498(20)31513-8.
  50. Petrosillo N, Viceconte G, Ergonul O et al. COVID-19, SARS and MERS: Are They Closely Related? Clin Microbiol Infect 2020;26(6):729-734.
  51. Nicastri E, Petrosillo N, Ascoli Bartoli et al. National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 Clinical Management. Infect Dis Report 2020 Mar 16;12(1):8543.
  52. Nicastri E, D’Abramo A, Faggioni G et al. Coronavirus Disease (COVID-19) in a Paucisymptomatic Patient: Epidemiological and Clinical Challenge in Settings With Limited Community Transmission, Italy, February 2020. Euro Surveill 2020 Mar;25(11):2000230.
  53. Viceconte G, Petrosillo N. COVID-19 R0: Magic Number or Conundrum? Infect Dis Rep 2020;12(1):8516.
  54. Albarello F, Pianura E, Di Stefano F et al. 2019-novel Coronavirus Severe Adult Respiratory Distress Syndrome in Two Cases in Italy: An Uncommon Radiological Presentation. Int J Infect Dis 2020;93:192-197.
  55. Davies K, Davis G, Barbut F, Eckert C, Petrosillo N, Pisapia R, Gärtner B, Berger FK, Reigadas E, Bouza E, Demont C, Wilcox MH. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see? Anaerobe. 2020 Apr;62:102178.
  56. Vena A, Giacobbe DR, Mussini C, Cattelan A, Bassetti M; Ceftabuse Study Group. Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa. Clin Infect Dis. 2020 Oct 23;71(7):1799-1801.
  57. Petrosillo N, Granata G, Boyle B, Doyle MM, Pinchera B, Taglietti F. Preventing sepsis development in complicated urinary tract infections. Expert Rev Anti Infect Ther. 2020 Jan;18(1):47-61. doi: 10.1080/14787210.2020.1700794.
  58. Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Dalla Gasperina D, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva) and the COLI-CROSS Study Group. Use of colistin in adult patients: A cross-sectional study. J Glob Antimicrob Resist. 2020 Mar;20:43-49. doi: 10.1016/j.jgar.2019.06.009.
  59. Nicastri E, Petrosillo N, Bartoli TA, Lepore L, Mondi A, Palmieri F, D’Offizi G, Marchioni L, Murachelli S, Ippolito G, Antinori A. National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep. 2020 Mar 16;12(1):8543. doi:10.4081/idr.2020.8543. PMID: 32218915; PMCID: PMC7097833.
  60. d’Arminio Monforte A, Tavelli A, Cozzi-Lepri A, Castagna A, Passerini S, Francisci D, Saracino A, Maggiolo F, Lapadula G, Girardi E, Perno CF, Antinori A; Icona Foundation Study Group. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort. J Antimicrob Chemother. 2020 Mar 1;75(3):681-689. doi: 10.1093/jac/dkz512. PMID: 31865395.
  61. Kozal M, Aberg J, Pialoux G, Cahn P, Thompson M, Molina JM, Grinsztejn B, Diaz R, Castagna A, Kumar P, Latiff G, DeJesus E, Gummel M, Gartland M, PierceA, Ackerman P, Llamoso C, Lataillade M; BRIGHTE Trial Team. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. N Engl J Med. 2020 Mar 26;382(13):1232-1243. doi: 10.1056/NEJMoa1902493. PMID: 32212519.
  62. Armenia D, Di Carlo D, Flandre P, Bouba Y, Borghi V, Forbici F, Bertoli A, Gori C, Fabeni L, Gennari W, Pinnetti C, Mondi A, Cicalini S, Gagliardini R,Vergori A, Bellagamba R, Malagnino V, Montella F, Colafigli M, Latini A, MaroccoR, Licthner M, Andreoni M, Mussini C, Ceccherini-Silberstein F, Antinori A, Perno CF, Santoro MM. HIV MDR is still a relevant issue despite its dramatic drop over the years. J Antimicrob Chemother. 2020 May 1;75(5):1301-1310. doi: 10.1093/jac/dkz554. PMID: 31976521.
  63. Gori A, Antinori A, Vergori A, Cossu MV, Menzaghi B, Sterrantino G, Rusconi S, Cattelan AM, Castelli F, Gianotti N, Orofino G, Ripamonti D, Savinelli S, Manzillo E, Santantonio TA, Celesia BM, Cauda R, Maserati R, dʼArminio Monforte A, Stingone C, Bonora S, Uglietti A, Termini R, Rucci F, Mancusi D. Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The “STORE” Study. J Acquir Immune Defic Syndr. 2020 Jul
  64. 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331. PMID: 32101882.
  65. Goletti D, Navarra A, Petruccioli E, Cimaglia C, Compagno M, Cuzzi G, De Carli G, Fondaco L, Franzetti F, Giannetti A, Gori A, Lapadula G, Lichtner M, Mastroianni CM, Mazzotta V, Orchi N, Pavone P, Piacentini D, Pirriatore V, Pontali E, Sarmati L, Spolti A, Tacconelli E, Galli M, Antinori A, Calcagno A, Girardi E. Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases. Int J Infect Dis. 2020 Mar;92:62-68. doi:10.1016/j.ijid.2019.12.031. Epub 2019 Dec 27. PMID: 31887456.
  66. Modica S, Redi D, Gagliardini R, Giombini E, Bezenchek A, Di Carlo D, Maggiolo F, Lombardi F, Borghetti A, Farinacci D, Callegaro A, Gismondo MR, Colafigli M, Sterrantino G, Costantini A, Ferrara SM, Rusconi S, Zazzi M, Rossetti B, De Luca A, Gianotti N. Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study. J Antimicrob Chemother. 2020 Jan 1;75(1):194-199. doi: 10.1093/jac/dkz424. PMID: 31605107.
  67. Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man CY, Urbaityte R, Brandon DJ, Underwood M, Tenorio AR, Pappa KA, Wynne B, Gartland M, Aboud M, van Wyk J, Smith KY. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment- Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials. J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):310-318. doi: 10.1097/QAI.0000000000002275. PMID: 31834000; PMCID: PMC7043729.
  68. Soulie C, Santoro MM, Storto A, Abdi B, Charpentier C, Armenia D, Jary A, Forbici F, Bertoli A, Gennari W, Andreoni M, Mussini C, Antinori A, Perno CF, Calvez V, Ceccherini-Silberstein F, Descamps D, Marcelin AG. Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral- experienced patients from two large databases in France and Italy. J Antimicrob Chemother. 2020 Apr 1;75(4):1026-1030. doi: 10.1093/jac/dkz553. PMID: 31976534.
  69. Amendola A, Sberna G, Forbici F, Abbate I, Lorenzini P, Pinnetti C, Antinori A, Capobianchi MR. The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring? PLoS One. 2020 Feb 5;15(2):e0228192. doi: 10.1371/journal.pone.0228192. Erratum in: PLoS One. 2020 Feb 27;15(2):e0230018. PMID: 32023284; PMCID: PMC7001951.
  70. Bordoni V, Sacchi A, Cimini E, Notari S, Grassi G, Tartaglia E, Casetti R, Giancola L, Bevilacqua N, Maeurer M, Zumla A, Locatelli F, De Benedetti F, Palmieri F, Marchioni L, Capobianchi MR, D’Offizi G, Petrosillo N, Antinori A, Nicastri E, Ippolito G, Agrati C. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19. Clin Infect Dis. 2020 May 15: ciaa577. doi: 10.1093/cid/ciaa577. Epub ahead of print. PMID: 32407466; PMCID: PMC7239202.
  71. Dickinson L, Gurjar R, Stöhr W, Bonora S, Owen A, D’Avolio A, Cursley A, Molina JM, Fäetkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Richert L, Raffi F, Boffito M; NEAT001/ANRS143 Study Group. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial. J Antimicrob Chemother. 2020 Mar 1;75(3):628-639. doi: 10.1093/jac/dkz479. PMID: 31754703.
  72. Boccara F, Kumar PN, Caramelli B, Calmy A, López JAG, Bray S, Cyrille M, Rosenson RS; BEIJERINCK Investigators. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study. J Am Coll Cardiol. 2020 May 26;75(20):2570-2584. doi: 10.1016/j.jacc.2020.03.025. Epub 2020 Mar 28. PMID: 32234462.
  73. Bordoni V, Sacchi A, Casetti R, Cimini E, Tartaglia E, Pinnetti C, Mondi A, Gruber CEM, Antinori A, Agrati C. Impact of ART on dynamics of growth factors and cytokines in primary HIV infection. Cytokine. 2020 Jan; 125:154839. doi: 10.1016/j.cyto.2019.154839. Epub 2019 Sep 19. PMID: 31542514.
  74. Scutari R, Alteri C, Vicenti I, Di Carlo D, Zuccaro V, Incardona F, Borghi V, Bezenchek A, Andreoni M, Antinori A, Perno CF, Cascio A, De Luca A, Zazzi M, Santoro MM; ARCA (Antiviral Response Cohort Analysis) Study Group. Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors. J Glob Antimicrob Resist. 2020 Mar; 20:163-169. doi: 10.1016/j.jgar.2019.07.015. Epub 2019 Jul 19. PMID: 31330378.
  75. Greenberg L, Ryom L, Wandeler G, Grabmeier-Pfistershammer K, Öllinger A, Neesgaard B, Stephan C, Calmy A, Rauch A, Castagna A, Spagnuolo V, Johnson M, Stingone C, Mussini C, De Wit S, Necsoi C, Campins AA, Pradier C, Stecher M, Wasmuth JC, Monforte AD, Law M, Puhr R, Chkhartishvilli N, Tsertsvadze T, Garges H, Thorpe D, Lundgren JD, Peters L, Bansi-Matharu L, Mocroft A; RESPOND Study Group. Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting. J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):240-250. doi: 10.1097/QAI.0000000000002250. PMID: 31923088.
  76. Antinori A, Cossu MV, Menzaghi B, Sterrantino G, Squillace N, Di Cristo V, Cattelan A, Focà E, Castagna A, Orofino G, Valenti D, D’Ettore G, Aprea L, Ferrara S, Locatelli ME, Madeddu G, Pontali E, Scerbo P, Rossetti B, Uglietti A, Termini R, Rucci F, Gori A, Mancusi D. Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. Patient. 2020 Jun;13(3):375-387. doi: 10.1007/s40271-020-00413-y. Erratum in: Patient. 2020 May 29; PMID: 32266663; PMCID: PMC7210246.
  77. Lathouwers E, Wong EY, Brown K, Baugh B, Ghys A, Jezorwski J, Mohsine EG, Van Landuyt E, Opsomer M, De Meyer S; AMBER and EMERALD Study Groups. Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials. AIDS Res Hum Retroviruses. 2020 Jan;36(1):48-57. doi: 10.1089/AID.2019.0111. Epub 2019 Oct 21. PMID: 31516033; PMCID: PMC6944133.
  78. Agrati C, Sacchi A, Bordoni V, Cimini E, Notari S, Grassi G, Casetti R, Tartaglia E, Lalle E, D’Abramo A, Castilletti C, Marchioni L, Shi Y, Mariano A, Song JW, Zhang JY, Wang FS, Zhang C, Fimia GM, Capobianchi MR, Piacentini M, Antinori A, Nicastri E, Maeurer M, Zumla A, Ippolito G. Expansion of myeloid- derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 Jun 8:1–12. doi: 10.1038/s41418-020-0572-6. Epub ahead of print. PMID: 32514047; PMCID: PMC7278239.
  79. Petruccioli E, Chiacchio T, Navarra A, Vanini V, Cuzzi G, Cimaglia C, Codecasa LR, Pinnetti C, Riccardi N, Palmieri F, Antinori A, Goletti D. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection. J Infect. 2020 May;80(5):536-546. doi: 10.1016/j.jinf.2020.02.009. Epub 2020 Feb 22. PMID: 32097688.
  80. Muscatello A, Nozza S, Fabbiani M, De Benedetto I, Ripa M, Dell’acqua R, Antinori A, Pinnetti C, Calcagno A, Ferrara M, Focà E, Quiros-Roldan E, Ripamonti D, Campus M, Maurizio Celesia B, Torti C, Cosco L, Di Biagio A, Rusconi S, Marchetti G, Mussini C, Gulminetti R, Cingolani A, D’ettorre G, Madeddu G, Franco A, Orofino G, Squillace N, Gori A, Tambussi G, Bandera A; Inaction Study Group.. Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. Pathog Immun. 2020 Feb 24;5(1):8-33. doi: 10.20411/pai. v5i1.341. PMID: 32258852; PMCID: PMC7104556.
  81. Messina F, Giombini E, Agrati C, Vairo F, Ascoli Bartoli T, Al Moghazi S, Piacentini M, Locatelli F, Kobinger G, Maeurer M, Zumla A, Capobianchi MR, Lauria FN, Ippolito G; COVID 19 INMI Network Medicine for IDs Study Group. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. Version 2. J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w. PMID: 32522207; PMCID: PMC7286221.
  82. Raffi F, Gaultier A, Pozniak A, Molina JM, Jessen H, Antinori A, Soria A, Cavellec M, Le Thuaut A, Ningre M, de Wit S. Five-year follow-up of patients enrolled in the NEAT 001/ANRS 143 randomized clinical trial: NEAT 001/ANRS 143 LONG TERM study. J Antimicrob Chemother. 2020 Jun 1;75(6):1618-1622. doi:10.1093/jac/dkaa056. PMID: 32211883.
  83. Cimini E, Sacchi A, Grassi G, Casetti R, Notari S, Bordoni V, Forini O, Grilli E, Vergori A, Capobianchi MR, Antinori A, Agrati C. Persistent gamma delta T-cell dysfunction in HCV/HIV co-infection despite direct-acting antiviral therapy-induced cure. J Viral Hepat. 2020 Jul;27(7):754-756. doi: 10.1111/jvh.13277. Epub 2020 Mar 2. PMID: 32049390.
  84. Floridia M, Ravizza M, Masuelli G, Tassis B, Savasi VM, Liuzzi G, Sansone M, Simonazzi G, Franceschetti L, Meloni A, Vimercati A, Guaraldi G, Pinnetti C, Dalzero S, Tamburrini E. Prevalence, Correlates and Outcomes of Smoking in Pregnant Women with HIV: A National Observational Study in Italy. Subst Use Misuse. 2020;55(7):1165-1172. doi: 10.1080/10826084.2020.1729204. Epub 2020 Feb 26. PMID: 32100603.
  85. Amendola A, Sberna G, Forbici F, Abbate I, Lorenzini P, Pinnetti C, Antinori A, Capobianchi MR. Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring? PLoS One. 2020 Feb 27;15(2):e0230018. doi: 10.1371/journal.pone.0230018. Erratum for: PLoS One. 2020 Feb 5;15(2):e0228192. PMID: 32108832; PMCID: PMC7046210.
    86. Antinori A, Cossu MV, Menzaghi B, Sterrantino G, Squillace N, Di Cristo V, Cattelan A, Focà E, Castagna A, Orofino G, Valenti D, D’Ettore G, Aprea L, Ferrara S, Locatelli ME, Madeddu G, Pontali E, Scerbo P, Rossetti B, Uglietti A, Termini R, Rucci F, Gori A, Mancusi D. Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. Patient. 2020 May 29. doi:10.1007/s40271-020-00425-8. Epub ahead of print. Erratum for: Patient. 2020Jun;13(3):375-387. PMID: 32468416.
  86. Benetti E, Tita R, Spiga O, Ciolfi A, Birolo G, Bruselles A, Doddato G, Giliberti A, Marconi C, Musacchia F, Pippucci T, Torella A, Trezza A, Valentino F, Baldassarri M, Brusco A, Asselta R, Bruttini M, Furini S, Seri M, Nigro V, Matullo G, Tartaglia M, Mari F; GEN-COVID Multicenter Study, Renieri A, Pinto AM.Eur J Hum Genet. 2020 Jul 17:1-13. doi: 10.1038/s41431-020-0691-z. Online ahead of print. PMID: 32681121 Free PMC article
  87. Armenia D, Bouba Y, Gagliardini R, Gori C, Bertoli A, Borghi V, Gennari W, Micheli V, Callegaro AP, Gazzola L, Bruzzone B, Giannetti A, Mazzotta V, Vergori A, Mastrorosa I, Colafigli M, Lichtner M, di Biagio A, Maggiolo F, Rizzardini G, d’Arminio Monforte A, Andreoni M, Mussini C, Antinori A, Ceccherini-Silberstein F, Perno CF, Santoro MM; Italian INI-Surveillance Group. Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings. J Clin Virol. 2020 Jul 11;130:104534. doi: 10.1016/j.jcv.2020.104534. Online ahead of print. PMID: 32769022
  88. Fabeni L, Santoro MM, Lorenzini P, Rusconi S, Gianotti N, Costantini A, Sarmati L, Antinori A, Ceccherini-Silberstein F, d’Arminio Monforte A, Saracino A, Girardi E, On Behalf Of The Icona Foundation Study Cohort. Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy. Viruses. 2020 Jul 23;12(8):E791. doi: 10.3390/v12080791. PMID: 32718024
  89. Agrati C, Mazzotta V, Pinnetti C, Biava G, Bibas M. Venous thromboembolism in people living with HIV infection (PWH). Transl Res. 2020 Jul 18:S1931-5244(20)30174-2. doi: 10.1016/j.trsl.2020.07.007. Online ahead of print. PMID: 32693031 Review
  90. Vergori A, Mastrorosa I, Pinnetti C, Camici M, Di Stefano F, Mastrobattista A, Vulcano A, Bartolini B, Granata G, Topino S, Amendola A, Antinori. Pneumocistis jiroveci Pneumonia in an AIDS-presenter Host: Missing the Target in the COVID-19 Epidemic [accepted; Arch Clin Med Case Rep 2020; 4 (5): 883-888. DOI: 10.26502/acmcr.96550275]
  91. Lanini S, Montaldo C, Nicastri E, Vairo F, Agrati C, Petrosillo N, Scognamiglio P, Antinori A, Puro V, Di Caro A, De Carli G, Navarra A, Agresta A, Cimaglia C, Palmieri F, D’Offizi G, Marchioni L, Kobinger GP, Maeurer M, Girardi E, Capobianchi MR, Zumla A, Locatelli F, Ippolito G. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020 Dec 28;15(12):e0244129. doi: 10.1371/journal.pone.0244129. eCollection 2020. PMID: 33370366 Free PMC article.
  92. Lombardi F, Giacomelli A, Armenia D, Lai A, Dusina A, Bezenchek A, Timelli L, Saladini F, Vichi F, Corsi P, Colao G, Bruzzone B, Gagliardini R, Callegaro A, Castagna A, Santoro MM; ARCA Study Group. Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database. Int J Antimicrob Agents. 2020 Nov 28:106252. doi:10.1016/j.ijantimicag.2020.106252. Online ahead of print. PMID: 33259914
  93. Andreoni M, Antinori A, Castagna A, D’Arminio Monforte A, Di Perri G, Galli M, Gori A, Mussini C, Perno CF. Beyond Italian guidelines in the management of HIV-positive patient. Infez Med. 2020 Nov 1;28(4):587-596. PMID: 33257635
  94. Vergori A, Rossetti B, Vicenti I, Meini G, Lentini G, Valoriani B, Caudai C, Morandi M, Cusi MG, Zazzi M, De Luca A. Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection. Infez Med. 2020 Nov 1;28(4):576-586. PMID: 33257634
  95. Galli L, Parisi MR, Poli A, Menozzi M, Fiscon M, Garlassi E, Francisci D, Di Biagio A, Sterrantino G, Fornabaio C, Degli Antoni A, Angarano G, Fusco FM, D’Arminio Monforte A, Corbelli GM, Santoro MM, Zazzi M, Castagna A; PRESTIGIO Study Group. Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry. Open Forum Infect Dis. 2020 Sep 26;7(11):ofaa456. doi: 10.1093/ofid/ofaa456. eCollection 2020 Nov. PMID: 33241063 Free PMC article.
  96. Bentzon AK, Panteleev A, Mitsura V, Borodulina E, Skrahina A, Denisova E, Tetradov S, Podlasin R, Riekstina V, Kancauskiene Z, Paduto D, Mocroft A, Trofimova T, Miller R, Post F, Grezesczuk A, Lundgren JD, Inglot M, Podlekareva D, Bolokadze N, Kirk O; TB:HIV Study Group. Healthcare delivery for HIV-positive people with tuberculosis in Europe. HIV Med. 2020 Nov 20. doi: 10.1111/hiv.13016. Online ahead of print. PMID: 33215809
  97. Del Nonno F, Frustaci A, Verardo R, Chimenti C, Nicastri E, Antinori A, Petrosillo N, Lalle E, Agrati C, Ippolito G; INMI COVID study group. Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series. Circ Heart Fail. 2020 Nov 12;13(11):CIRCHEARTFAILURE120007636. doi: 10.1161/CIRCHEARTFAILURE.120.007636. Online ahead of print. PMID: 33176456 Free PMC article.
  98. Sacchi A, Grassi G, Bordoni V, Lorenzini P, Cimini E, Casetti R, Tartaglia E, Marchioni L, Petrosillo N, Palmieri F, D’Offizi G, Notari S, Tempestilli M, Capobianchi MR, Nicastri E, Maeurer M, Zumla A, Locatelli F, Antinori A, Ippolito G, Agrati C. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 Oct 27;11(10):921. doi: 10.1038/s41419-020-03125-1.PMID: 33110074 Free PMC article
  99. Teofili L, Landolfi R, Cingolani A, Antinori A, Vecchiet J, Sanguinetti M, Gasbarrini A, Pasciuto T, Orlando N, Lamonica S. “Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial”. Trials. 2020 Oct 22;21(1):875. doi: 10.1186/s13063-020-04821-1. PMID: 33092632 Free PMC article. Clinical Trial.
  100. Bordi L, Sberna G, Lalle E, Piselli P, Colavita F, Nicastri E, Antinori A, Boumis E, Petrosillo N, Marchioni L, Minnucci G, D’Agostini E, Castilletti C, Locatelli F, Zumla A, Ippolito G, Capobianchi MR, On Behalf Of Inmi ReCOVeRI Study Group. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 Oct 20;12(10):1184. doi: 10.3390/v12101184.PMID: 33092065 Free PMC article.
  101. Petrone L, Petruccioli E, Vanini V, Cuzzi G, Najafi Fard S, Alonzi T, Castilletti C, Palmieri F, Gualano G, Vittozzi P, Nicastri E, Lepore L, Antinori A, Vergori A, Caccamo N, Cantini F, Girardi E, Ippolito G, Grifoni A, Goletti D. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2020 Oct 10:S1198-743X(20)30605-4. doi: 10.1016/j.cmi.2020.09.051. Online ahead of print. PMID: 33045370 Free PMC article.
  102. COVID-19 RISk and Treatments (CORIST) Collaboration. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. Vascul Pharmacol. 2020 Dec;135:106805. doi: 10.1016/j.vph.2020.106805. Epub 2020 Sep 28. PMID: 32992048 Free PMC article.
  103. Mondi A, Cimini E, Colavita F, Cicalini S, Pinnetti C, Matusali G, Casetti R, Maeurer M, Vergori A, Mazzotta V, Gagliardini R, De Zottis F, Schininà V, Girardi E, Puro V, Ippolito G, Vaia F, Capobianchi MR, Castilletti C, Agrati C, Antinori A. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. J Med Virol. 2020 Sep 25:10.1002/jmv.26556. doi: 10.1002/jmv.26556. Online ahead of print. PMID: 32975842 Free PMC article.
  104. Pinnetti C, Vergori A, Agrati C, Castilletti C, Campioni P, Gagliardini R, Mondi A, Notari S, Amendola A, Cicalini S, Baldini F, Capobianchi MR, Antinori A. SARS-CoV-2 infection does not induce HIV viral escape in the central nervous system: A case series. Int J Infect Dis. 2020 Dec;101:38-41. doi: 10.1016/j.ijid.2020.09.040. Epub 2020 Sep 17. PMID: 32950740 Free PMC article.
  105. Vergori A, Gagliardini R, Gianotti N, Gori A, Lichtner M, Saracino A, De Vito A, Cascio A, Di Biagio A, Monforte AD, Antinori A, Cozzi-Lepri A; ICONA Foundation Study Network. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? Int J Antimicrob Agents. 2020 Dec;56(6):106154. doi: 10.1016/j.ijantimicag.2020.106154. Epub 2020 Sep 10. PMID: 32919008
  106. Aghemo A, Alberti A, Andreone P, Angelico M, Brunetto MR, Chessa L, Ciancio A, Craxì A, Gaeta GB, Galli M, Gasbarrini A, Giorgini A, Grilli E, Lampertico P, Lichtner M, Milella M, Morisco F, Persico M, Pirisi M, Puoti M, Raimondo G, Romano A, Russello M, Sangiovanni V, Schiavini M, Serviddio G, Villa E, Vinci M, De Michina A, Gallinaro V, Gualberti G, Roscini AS, Zignego AL; MARS Study Group. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study. Dig Liver Dis. 2020 Sep 8:S1590-8658(20)30401-1. doi: 10.1016/j.dld.2020.08.007. Online ahead of print. PMID: 32917546.
  107. Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D’Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 Nov 9;222(11):1807-1815. doi: 10.1093/infdis/jiaa578. PMID: 32914853 Free PMC article.
  108. Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N, Blandi L, Bruno R, Cauda R, Guaraldi G, My I, Menicanti L, Parruti G, Patti G, Perlini S, Santilli F, Signorelli C, Stefanini GG, Vergori A, Abdeddaim A, Ageno W, Agodi A, Agostoni P, Aiello L, Al Moghazi S, Aucella F, Barbieri G, Bartoloni A, Bologna C, Bonfanti P, Brancati S, Cacciatore F, Caiano L, Cannata F, Carrozzi L, Cascio A, Cingolani A, Cipollone F, Colomba C, Crisetti A, Crosta F, Danzi GB, D’Ardes D, de Gaetano Donati K, Di Gennaro F, Di Palma G, Di Tano G, Fantoni M, Filippini T, Fioretto P, Fusco FM, Gentile I, Grisafi L, Guarnieri G, Landi F, Larizza G, Leone A, Maccagni G, Maccarella S, Mapelli M, Maragna R, Marcucci R, Maresca G, Marotta C, Marra L, Mastroianni F, Mengozzi A, Menichetti F, Milic J, Murri R, Montineri A, Mussinelli R, Mussini C, Musso M, Odone A, Olivieri M, Pasi E, Petri F, Pinchera B, Pivato CA, Pizzi R, Poletti V, Raffaelli F, Ravaglia C, Righetti G, Rognoni A, Rossato M, Rossi M, Sabena A, Salinaro F, Sangiovanni V, Sanrocco C, Scarafino A, Scorzolini L, Sgariglia R, Simeone PG, Spinoni E, Torti C, Trecarichi EM, Vezzani F, Veronesi G, Vettor R, Vianello A, Vinceti M, De Caterina R, Iacoviello L; COvid-19 RISk and Treatments (CORIST) collaboration. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913. doi: 10.1016/j.numecd.2020.07.031. Epub 2020 Jul 31. PMID: 32912793
  109. COVID-19 RISK and Treatments (CORIST) Collaboration. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study. Eur J Intern Med. 2020 Dec;82:38-47. doi: 10.1016/j.ejim.2020.08.019. Epub 2020 Aug 25. PMID: 32859477 Free PMC article.
  110. Bordoni V, Tartaglia E, Refolo G, Sacchi A, Grassi G, Antinori A, Fimia GM, Agrati C. Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection. Front Cell Infect Microbiol. 2020 Jul 21;10:362. doi: 10.3389/fcimb.2020.00362. eCollection 2020. PMID: 32850472 Free PMC article.
  111. Tempestilli M, Caputi P, Avataneo V, Notari S, Forini O, Scorzolini L, Marchioni L, Ascoli Bartoli T, Castilletti C, Lalle E, Capobianchi MR, Nicastri E, D’Avolio A, Ippolito G, Agrati C; COVID 19 INMI Study Group. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. J Antimicrob Chemother. 2020 Oct 1;75(10):2977-2980. doi: 10.1093/jac/dkaa239. PMID: 32607555 Free PMC article.
  112. Canetti D, Galli L, Gianotti N, Celotti A, Calza L, Gagliardini R, Rusconi S, Modica S, Cenderello G, Ferrara M, Santoro MM, Zazzi M, Castagna A; PRESTIGIO Study Group. Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry. J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):e24-e28. doi: 10.1097/QAI.0000000000002378. PMID: 32598119 No abstract available.
  113. Mocroft A, Neesgard B, Zangerle R, Rieger A, Castagna A, Spagnuolo V, Antinori A, Lampe FC, Youle M, Vehreschild JJ, Mussini C, Borghi V, Begovac J, Duvivier C, Gunthard HF, Rauch A, Tiraboschi J, Chkhartishvili N, Bolokadze N, Wit F, Wasmuth JC, De Wit S, Necsoi C, Pradier C, Svedhem V, Stephan C, Petoumenos K, Garges H, Rogatto F, Peters L, Ryom L; RESPOND study group. Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment. HIV Med. 2020 Oct;21(9):599-606. doi: 10.1111/hiv.12888. Epub 2020 Jun 26. PMID: 32588958
  114. Taramasso L, Fabbiani M, Nozza S, De Benedetto I, Bruzzesi E, Mastrangelo A, Pinnetti C, Calcagno A, Ferrara M, Bozzi G, Focà E, Quiros-Roldan E, Ripamonti D, Campus M, Celesia BM, Torti C, Cosco L, Di Biagio A, Rusconi S, Marchetti G, Mussini C, Gulminetti R, Cingolani A, d’Ettorre G, Madeddu G, Franco A, Orofino G, Squillace N, Muscatello A, Gori A, Antinori A, Tambussi G, Bandera A; INACTION study group. Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24. PMID: 32578947
  115. Lepore L, Vairo F, D’Abramo A, Grilli E, Corpolongo A, Scorzolini L, Nisii C, Calleri G, Castelli F, Chirianni A, Ippolito G, Nicastri E. Clinical management of imported malaria in Italy: results from a national cross-sectional survey in 2015. New Microbiol. 2020 Jan;43(1):28-33. Epub 2020 Mar 1. PMID: 32118282
  116. Amendola A, Sberna G, Forbici F, Abbate I, Lorenzini P, Pinnetti C, Antinori A, Capobianchi MR. Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring? PLoS One. 2020 Feb 27;15(2):e0230018. doi: 10.1371/journal.pone.0230018. eCollection 2020. PMID: 32108832 Free PMC article
  117. Pianura E, Di Stefano F, Cristoforo M, Petrone A, Albarello F, Lapa D, Cicalini S, Campioni P, Schininà V. CORONAVIRUS-HKU1 PNEUMONIA AND DIFFERENTIAL DIAGNOSIS WITH COVID19. Radiology Cardiothoracic Imaging. In press
  118. Pianura E, Di Stefano F, Cristoforo M, Petrone A, Albarello F, Lapa D, Cicalini S, Campioni P, Schininà V. CORONAVIRUS-HKU1 PNEUMONIA AND DIFFERENTIAL DIAGNOSIS WITH COVID19. Radiology Cardiothoracic Imaging. In Press
  119. G, Yang P, Xie Y, et al. Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study. Eur Respir J. 2020;56(2):2001104. doi:10.1183/13993003.01104-2020
  120. Tempestilli M, Caputi P, Avataneo V, et al. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. J Antimicrob Chemother. 2020;dkaa239. doi:10.1093/jac/dkaa239
  121. D’Abramo A, Lepore L, Palazzolo C, et al. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature. Int J Infect Dis. 2020; 97:236-239. doi:10.1016/j.ijid.2020.06.056
  122. Messina F, Giombini E, Agrati C,et al on COVID 19 INMI Network Medicine for IDs Study Group. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. Version 2. J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w.
  123. Agrati C, Sacchi A, Bordoni V, et al . Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 Jun 8:1-12. doi: 10.1038/s41418-020-0572-6.
  124. Gentilotti E, De Nardo P, Nguhuni B, et al. Implementing a combined infection prevention and control with antimicrobial stewardship joint program to prevent caesarean section surgical site infections and antimicrobial resistance: a Tanzanian tertiary hospital experience. Antimicrob Resist Infect Control. 2020 May 19;9(1):69. doi: 10.1186/s13756-020-00740-7.
  125. Bordoni V, Sacchi A, Cimini E, et al. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19. Clin Infect Dis. 2020 May 15:ciaa577. doi: 10.1093/cid/ciaa577.
  126. Cantini F, Niccoli L, Matarrese D, Nicastri E, Stobbione P, Goletti D. Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact. J Infect. 2020 Apr 23:S0163-4453(20)30228-0. doi: 10.1016/j.jinf.2020.04.017.
  127. Cantini F, Niccoli L, Nannini C, et al. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study. J Infect. 2020;S0163-4453(20)30433-3. doi:10.1016/j.jinf.2020.06.052
  128. Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann Intern Med. 2020 Apr 17:M20-1176. doi: 10.7326/M20-1176.
  129. Scorzolini L, Corpolongo A, Castilletti C, Lalle E, Mariano A, Nicastri E. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection. Clin Infect Dis. 2020 Apr 16:ciaa445. doi: 10.1093/cid/ciaa445.
  130. Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
  131. Capobianchi MR, Rueca M, Messina F, et al. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin Microbiol Infect. 2020 Mar 27. doi: 10.1016/j.cmi.2020.03.025
  132. Nicastri E, Petrosillo N, Bartoli TA, et al National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep. 2020 Mar 16;12(1):8543. doi: 10.4081/idr.2020.8543. eCollection 2020 Feb 25.
  133. Nicastri E, D’Abramo A, Faggioni G, et al, On Behalf Of Inmi And The Italian Army Covid-Study Groups. Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020. Euro Surveill. 2020 Mar; 25(11):2000230. doi: 10.2807/1560-7917.ES.2020.25.11.2000230.
  134. Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020 Mar;25(9):2000178. doi: 10.2807/1560-7917.ES.2020.25.9.2000178.
  135. Albarello F, Pianura E, Di Stefano F, et al; COVID 19 INMI Study Group. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. Int J Infect Dis. 2020 Apr;93:192-197. doi: 10.1016/j.ijid.2020.02.043. Epub 2020 Feb 26.
  136. Bordi L, Nicastri E, Scorzolini L, et al, On Behalf Of Inmi Covid-Study Group And Collaborating Centers. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveill. 2020 Feb;25(8):2000170. doi: 10.2807/1560-7917.ES.2020.25.8.2000170.
  137. Lepore L, Vairo F, D’Abramo A, et al. Clinical management of imported malaria in Italy: results from a national cross-sectional survey in 2015. New Microbiol. 2020 Jan;43(1):28-33. Epub 2020 Mar 1.
  138. Díaz-Menéndez M, Esteban ET, Ujiie M, et al. Travel-associated chikungunya acquired in Myanmar in 2019. Euro Surveill. 2020 Jan; 25(1):1900721. doi: 10.2807/1560-7917.ES.2020.25.1.1900721.
  139. Palazzolo C, Maffongelli G, D’Abramo A, et al. Legionella pneumonia: increased risk after COVID-19 lockdown? Italy, May to June 2020. Euro Surveill. 2020;25(30):2001372. doi:10.2807/1560-7917.ES.2020.25.30.2001372.
  140. Palazzolo C, Maffongelli G, D’Abramo A, et al. Authors’ response: importance of a careful investigation to avoid attributing Legionnaires’ disease cases to an incorrect source of infection. Euro Surveill. 2020;25(34):10.2807/1560-7917.ES.2020.25.34.2001570. doi:10.2807/1560-7917.ES.2020.25.34.2001570.
  141. De Nardo P, Gentilotti E, Mazzaferri F, et al. Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage. Int J Infect Dis. 2020;98:494-500. doi:10.1016/j.ijid.2020.06.082
  142. L’Episcopia M, Bartoli TA, Corpolongo A, et al. Artemisinin resistant surveillance in African Plasmodium falciparum isolates from imported malaria cases to Italy. J Travel Med. 2020 Dec 9:taaa231. doi: 10.1093/jtm/taaa231.
  143. Vita S, Di Bari V, Corpolongo A, et al. Down Syndrome patients with COVID-19 pneumonia: a high-risk category for unfavourable outcome. Int J Infect Dis. 2020 Nov 30:S1201-9712(20)32503-0.
  144. Del Nonno F, Frustaci A, Verardo R, et al. Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series. Circ Heart Fail. 2020 Nov 12;13(11): 10.1161
  145. Sacchi A, Grassi G, Bordoni V et al. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 Oct 27;11(10):921
  146. Bordi L, Sberna G, Lalle E, et al. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 Oct 20;12(10):1184.
  147. Petrone L, Petruccioli E, Vanini V, et al. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2020 Oct 10:S1198-743X(20)30605-4.
  148. Vairo F, Aimè Coussoud-Mavoungou MP, Ntoumi F, et al. Chikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation. Viruses. 2020 Sep 13;12(9):1020.
  149. Falasca L, Nardacci R, Colombo D, et al. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 Nov 9;222(11):1807-1815.
  150. Carsetti R, Zaffina S, Piano Mortari E, et al. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol. 2020 Dec 16;11:610300.
  151. Lanini S, Montaldo C, Nicastri E, et al. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020 Dec 28;15(12):e0244129.
  152. Gualano G, Musso M, Mosti S, …, Palmieri F. Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report. Int J Infect Dis 2020; S1201-9712(20)30334-9.
  153. Di Gennaro F, Vittozzi P, Gualano G, …, Palmieri F. Active Pulmonary Tuberculosis in Elderly Patients: A 2016-2019 Retrospective Analysis from an Italian Referral Hospital. Antibiotics (Basel). 2020; 9(8): E489. doi: 10.3390/antibiotics9080489.
  154. Tadolini M, Codecasa LR, García-García JM, et al (Palmieri F, Gualano G). Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020; 56(1): 2001398.
  155. Motta I, Centis R, D’Ambrosio L, et al (Gualano G, Palmieri F). Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology 2020; 26: 233-240.
  156. Mencarini P, Scarabello A, Del Nonno F, …, Palmieri F. Dermatological manifestations during COVID-19 and histological picture: Description of two clinical cases. J Dermatol (accepted manuscript).
  157. Musso M, GualanoG, Di Gennaro F, …, Palmieri F. Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy: a case report. Infection (accepted manuscript).
  158. Vita S, Di Bari V, Corpolongo A, Goletti D, Espinosa J, Petracca S, Palmieri F, Nicastri E; INMI COVID-19 study groups. Down Syndrome patients with COVID-19 pneumonia: a high-risk category for unfavourable outcome. Int J Infect Dis. 2020: S1201-9712(20)32503-0.
  159. Motta I, Centis R, D’Ambrosio L, et al (Palmieri F, Gualano G). Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts [published online ahead of print, 2020 May 14]. Pulmonology 2020;10.1016
  160. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
  161. Migliori GB, Thong PM, Akkerman O, et al (Gualano G, Palmieri F). Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis 2020: 26: 2709-2712.
  162. Bordoni V, Sacchi A, Cimini E, et al (Palmieri F). An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19 [published online ahead of print, 2020 May 15]. Clin Infect Dis 2020; ciaa577
  163. Nicastri E, Petrosillo N, Bartoli TA, et al (Palmieri F). National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep 2020;12(1):8543. Published 2020 Mar 16.
  164. Petrone L, Petruccioli E, Vanini V, et al (Palmieri F, Gualano G, Vittozzi P).. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect 2020: S1198-743X(20)30605-4.
  165. Petruccioli E, Chiacchio T, Navarra A, et al (Palmieri F). Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection. J Infect
  166. Carsetti R, Zaffina S, Piano Mortari E, et al (Palmieri F). Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol. 2020; 11:610300.
  167. Lanini S, Montaldo C, Nicastri E, et al (Palmieri F). COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One 2020; 15(12):e0244129.
  168. Sacchi A, Grassi G, Bordoni V, et al (Palmieri F). Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis 2020; 11(10): 921.
  169. Sala C, Benjak A, Goletti D, et al (Palmieri F). Multicenter analysis of sputum microbiota in tuberculosis patients. PLoS One 2020; 15(10):e0240250.
  170. Falasca L, Nardacci R, Colombo D, et al (Palmieri F). Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis 2020; 222(11): 1807-1815.
  171. Emanuele Nicastri , Alessandra D’Abramo , Giovanni Faggioni , et al. , on behalf of. INMI and the Italian Army COVID-19 study groups⁷ CORONAVIRUS DISEASE (COVID-19) IN A PAUCISYMPTOMATIC PATIENT: EPIDEMIOLOGICAL AND CLINICAL CHALLENGE IN SETTINGS WITH LIMITED COMMUNITY TRANSMISSION, ITALY, FEBRUARY 2020. Rapid communication . Euro Surveill. 2020 Mar;25(11):2000230. doi: 10.2807/1560-7917.ES.2020.25.11.2000230
  172. Licia Bordi, 1 Emanuele Nicastri, 1 Laura Scorzolini, et al. and on behalf of INMI COVID-19 study group and Collaborating Centers 2. DIFFERENTIAL DIAGNOSIS OF ILLNESS IN PATIENTS UNDER INVESTIGATION FOR THE NOVEL CORONAVIRUS (SARS-COV-2), ITALY, FEBRUARY 2020. Euro Surveill. 2020 Feb 27; 25(8): 2000170. doi: 10.2807/1560-7917.ES.2020.25.8.2000170 PMCID: PMC7055037 PMID: 32127123
  173. Fabrizio Albarello , Elisa Pianura , Federica Di Stefano ,et al, COVID 19 INMI Study Group. 2019-NOVEL CORONAVIRUS SEVERE ADULT RESPIRATORY DISTRESS SYNDROME IN TWO CASES IN ITALY: AN UNCOMMON RADIOLOGICAL PRESENTATION.Case Reports Int J Infect Dis. 2020 Apr;93:192-197. Doi 10.1016/j.ijid.2020.02.043. Epub 2020 Feb 26. PMID: 32112966 PMCID: PMC7110436 DOI: 10.1016/j.ijid.2020.02.043
  174. Emanuele Nicastri 1, Nicola Petrosillo 1, Tommaso Ascoli Bartoli 1,et al. NATIONAL INSTITUTE FOR THE INFECTIOUS DISEASES “L. SPALLANZANI”, IRCCS. RECOMMENDATIONS FOR COVID-19 CLINICAL MANAGEMENT. Infect Dis Rep. 2020 Mar 16;12(1):8543. doi: 10.4081/idr.2020.8543. eCollection 2020 Feb 25. PMID: 32218915 PMCID: PMC7097833 DOI: 10.4081/idr.2020.8543
  175. Veronica Bordoni,1 Alessandra Sacchi,1 Eleonora Cimini, et al. AN INFLAMMATORY PROFILE CORRELATES WITH DECREASED FREQUENCY OF CYTOTOXIC CELLS IN COVID-19. Clin Infect Dis. 2020 May 15;ciaa577. PMID: 32407466 DOI: 10.1093/cid/ciaa577.
  176. Francesca Colavita, Daniele Lapa, Fabrizio Carletti,et al Appendix: INMI COVID-19 Study Group. SARS-COV-2 ISOLATION FROM OCULAR SECRETIONS OF A PATIENT WITH COVID-19 IN ITALY WITH PROLONGED VIRAL RNA DETECTION. Ann Intern Med. 2020 Apr 17;M20-1176. doi: 10.7326/M20-1176
  177. Chiara Agrati , Alessandra Sacchi, Veronica Bordoni, Eleonora Cimini, et al. EXPANSION OF MYELOID-DERIVED SUPPRESSOR CELLS IN PATIENTS WITH SEVERE CORONAVIRUS DISEASE (COVID-19). Cell Death & Differentiation https://doi.org/10.1038/s41418-020-0572-6.
  178. Tempestilli M, Caputi P, Avataneo V, et al. PHARMACOKINETICS OF REMDESIVIR AND GS-441524 IN TWO CRITICALLY ILL PATIENTS WHO RECOVERED FROM COVID-19. J Antimicrob Chemother. 2020 Jul 1:dkaa239. doi: 10.1093/jac/dkaa239. Online ahead of print. PMID: 32607555.
  179. Martina Rueca, Barbara Bartolini, Cesare Ernesto Maria Gruber,et al.COMPARTMENTALIZED REPLICATION OF SARS-COV-2 IN UPPER VS. LOWER RESPIRATORY TRACT ASSESSED BY WHOLE GENOME QUASISPECIES ANALYSIS. Microorganisms 2020, 8(9), 1302; https://doi.org/10.3390/microorganisms8091302
  180. Colavita Francesca1, Brogi Alessandra2, Lapa Daniele1 et al., , on behalf of the INMI Covid-19 laboratory team. 1 National Institute for Infectious Diseases “L. Spallanzani” IRCCS, Rome, Italy. 2 DIESSE Diagnostica Senese S.p.A., Siena, Italy. EVALUATION OF ELISA TESTS FOR THE QUALITATIVE DETERMINATION OF IGG, IGM AND IGA TO SARSCOV-2 . medRxiv preprin doi:https://doi.org/10.1101/2020.05.24.20111682 this version posted May 26, 2020
  181. Rita Carsetti1,2*, Salvatore Zaffina3,4, Eva Piano Mortari1#,et al. SPECTRUM OF INNATE AND ADAPTIVE IMMUNE RESPONSE TO SARS-COV-2 INFECTION ACROSS ASYMPTOMATIC, MILD AND SEVERE CASES – A LONGITUDINAL COHORT STUDY medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20137141 this version posted June 23, 2020.
  182. Laura Falasca1*, Roberta Nardacci1*#, Daniele Colombo1, et al, on behalf of COVID 19 INMI Study Group. POST-MORTEM FINDINGS IN ITALIAN PATIENTS WITH COVID-19 – A DESCRIPTIVE FULL AUTOPSY STUDY OF CASES WITH AND WITHOUT CO-MORBIDITIES The Journal of Infectious Diseases , jiaa578, https://doi.org/10.1093/infdis/jiaa578
  183. Rita Carsetti , Salvatore Zaffina , Eva Piano Mortari , et al. DIFFERENT INNATE AND ADAPTIVE IMMUNE RESPONSE TO SARS-COV-2 INFECTION OF ASYMPTOMATIC, MILD AND SEVERE CASES medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20137141.t
  184. Licia Bordi 1, Giuseppe Sberna 1, Eleonora Lalle, et al. and on behalf of INMI ReCOVeRI Study Group ‡ FREQUENCY AND DURATION OF SARS-COV-2 SHEDDING IN ORAL FLUID SAMPLES ASSESSED BY A MODIFIED COMMERCIAL RAPID MOLECULAR ASSAY. Virus 2020 , 12 (10), 1184; https://doi.org/10.3390/v12101184
  185. Alessandra Sacchi ,Germana Grassi ,Veronica Bordoni ,et al. EARLY EXPANSION OF MYELOID-DERIVED SUPPRESSOR CELLS INHIBITS SARS-COV-2 SPECIFIC T-CELL RESPONSE AND MAY PREDICT FATAL COVID-19 OUTCOME Cell Death and Disease (2020) 11:921https://doi.org/10.1038/s41419-020-03125-1
  186. Q Piacevoli1*, L Marchioni2 and G Garotto2 AUTOPSIES FINDINGS AND EVOLUTION OF THE THERAPEUTIC STRATEGIES OF THE SARS-COV-2 Acta Scientific MEDICAL SCIENCES (ISSN: 2582-0931) . Volume 4 Issue 11 November 2020
  187. Maria Adriana Cataldo, Nardi Tetaj Marina Selleri et al. la co-infezione INMI COVID-19 gruppo 1. INCIDENCE OF BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN COVID-19 PATIENTS IN INTENSIVE CARE: AN ALARMING “COLLATERAL EFFECT” Journal of Global Antimicrobial Resistance https://doi.org/10.1016/j.jgar.2020.10.004
  188. Serena Vita1 , M.D., Ph.D., Virginia Di Bari1 , et al. on behalf of INMI COVID-19 study groups4 DOWN SYNDROME PATIENTS WITH COVID-19 PNEUMONIA: A HIGH-RISK CATEGORY FOR UNFAVOURABLE OUTCOME International Journal of Infectious Diseases 24 November 2020. DOI: https://doi.org/10.1016/j.ijid.2020.11.188
  189. Rita Carsetti 1,2*, Salvatore Zaffina3,4, Eva Piano Mortari 1†, et al. DIFFERENT INNATE AND ADAPTIVE IMMUNE RESPONSES TO SARS-COV-2 INFECTION OF ASYMPTOMATIC, MILD, AND SEVERE CASES Front. Immunol., 16 dicembre 2020 | https://doi.org/10.3389/fimmu.2020.610300.
  190. Simone LaniniI, Chiara MontaldoI, Emanuele Nicastri, et al. COVID-19 DISEASE—TEMPORAL ANALYSES OF COMPLETE BLOOD COUNT PARAMETERS OVER COURSE OF ILLNESS, AND RELATIONSHIP TO PATIENT DEMOGRAPHICS AND MANAGEMENT OUTCOMES IN SURVIVORS AND NON SURVIVORS: A LONGITUDINAL DESCRIPTIVE COHORT STUDY PLOS ONE | https://doi.org/10.1371/journal.pone.0244129 December 28, 2020
  191. Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series Del Nonno F, Frustaci A, Verardo R, Chimenti C, Nicastri E, Antinori A, Petrosillo N, Lalle E, Agrati C, Ippolito G; INMI COVID study group. Circ Heart Fail. 2020 Nov 12;13(11):. doi: 10.1161/CIRCHEARTFAILURE.120.007636. Online ahead of print.
  192. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without ComorbiditiesFalasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D’Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. J Infect Dis. 2020 Nov 9;222(11):1807-1815. doi: 10.1093/infdis/jiaa578.
  193. Fatal Takotsubo Syndrome in critical COVID-19 related pneumonia Titi L, Magnanimi E, Mancone M, Infusino F, Coppola G, Del Nonno F, Colombo D, Nardacci R, Falasca L, d’Amati G, Tarsitano MG, Merlino L, Fedele F, Pugliese F. Cardiovasc Pathol. 2020 Nov 28:107314. doi: 10.1016/j.carpath.2020.107314. Online ahead of print.
  194. Severe palmar hyperkeratosis and hematochezia in COVID-19 Tammaro A, Adebanjo GAR, Chello C, Parisella FR, Rello J, Del Nonno F, Scarabello A. Dermatol Ther. 2020 Oct 18:e14423. doi: 10.1111/dth.14423. Online ahead of print.
  195. Cutaneous Endothelial Dysfunction and Complement Deposition in COVID-19 Tammaro A, Adebanjo GAR, Del Nonno F, Pezzuto A, Ramirez-Estrada S, Parisella FR, Rello J, Scarabello A. Am J Dermatopathol. 2020 Oct 13. doi: 10.1097/DAD.0000000000001825. Online ahead of print.
  196. Dermatological manifestations during COVID-19 and histological picture: description of two clinical cases Mencarini Paola; Scarabello Alessandra; Del Nonno Franca; Lalle Eleonora; Falasca Laura; Gualano Gina; Nardacci Roberta; Mosti Silvia; Musso Maria; Libertone Raffaella; Di Bari Virginia; Rosati Silvia; Colombo Daniele; Castilletti Concetta; Palmieri Fabrizio
  197. Human papillomavirus infections in cervical samples from HIV-positive women: evaluation of the presence of the nonavalent HPV genotypes and genetic diversity
    Catia Sias, Valerio Guarrasi, Claudia Minosse, Daniele Lapa, Franca Del Nonno, Maria Rosaria Capobianchi, Anna Rosa Garbuglia, Paola Del Porto, Paola Paci
    Manuscript ID: 603657 Frontiers in Microbiology, section Virology Accettato
  198. Natale F, De Curtis M, Bizzarri B, Orlando MP, Ralli M, Liuzzi G, Caravale B, Franco F, Gaeta A, Giancotti A, Russo FY, Turchetta R. Isolated auditory neuropathy at birth in congenital cytomegalovirus infection. Ital J Pediatr. 2020 Jan 6;46(1):3. doi: 10.1186/s13052-019-0767-y. PMID: 31906974; PMCID: PMC6945599.
  199. Floridia M, Ravizza M, Masuelli G, Tassis B, Savasi VM, Liuzzi G, Sansone M, Simonazzi G, Franceschetti L, Meloni A, Vimercati A, Guaraldi G, Pinnetti C, Dalzero S, Tamburrini E. Prevalence, Correlates and Outcomes of Smoking in Pregnant Women with HIV: A National Observational Study in Italy. Subst Use Misuse. 2020;55(7):1165-1172. doi: 10.1080/10826084.2020.1729204. Epub 2020 Feb 26. PMID: 32100603.
  200. D’Abramo A, Lepore L, Palazzolo C, Barreca F, Liuzzi G, Lalle E, Nicastri E. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature. Int J Infect Dis. 2020 Aug;97:236-239. doi: 10.1016/j.ijid.2020.06.056. Epub 2020 Jun 18. PMID: 32565366; PMCID: PMC7301795.
  201. Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D’Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 Nov 9;222(11):1807-1815
  202. Agrati C, Mazzotta V, Pinnetti C, Biava G, Bibas M. Venous thromboembolism in people living with HIV infection (PWH). In corso di pubblicazione su Transl Res.
Torna all'inizio dei contenuti